Epigral Limited (EPIGRAL) — Financial Results

· NSE 🔴 High Importance Neutral
Revenue: ₹736 CrNet Profit: ₹82
📢 Key Event
Epigral Limited reported Q4 FY26 revenue of ₹736 crores, up 22% QoQ, with PAT at ₹330 crores including a one-time INR81 crore tax benefit.
💡 Investor Takeaway
The company expects FY27 volume growth of 10-12% and plans capacity expansions to drive long-term growth despite geopolitical headwinds.

Epigral Limited reported Q4 FY26 revenue of ₹736 crores, up 22% QoQ, driven by 15% volume growth and 78-85% plant utilization, with EBITDA margin expanding to 23%. Full-year FY26 revenue declined 1% to ₹2,542 crores due to a 4% volume drop, but PAT reached ₹330 crores, including a one-time INR81 crore tax benefit. Management targets FY27 volume growth of 10-12% and expects resilience through product diversification despite geopolitical risks from West Asia affecting raw material prices and supply chains. Energy costs rose 15% due to conflict, but renewable energy adoption (currently 8-9% of power mix) is being leveraged for insulation. Net debt stood at INR508 crores with a debt-to-EBITDA ratio of 0.9.

📄 View Original Announcement (PDF)

About Epigral Limited (EPIGRAL)

Chemicals · Chemicals & Petrochemicals · Listed on NSE

Market Cap: ₹5,247.71 Cr P/E: 14.6

View full EPIGRAL stock details →

📡 Get AI alerts when EPIGRAL files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track EPIGRAL — Free

📊 More EPIGRAL filings

See all EPIGRAL filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when EPIGRAL files new disclosures

Track EPIGRAL filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track EPIGRAL — Free

Free account · 2 AI queries/day